Medical Imaging Gateway
Welcome to BioMed Central's Medical Imaging Gateway, highlighting the latest articles we have published in this field as well as news items of interest. Content is continually updated, so please bookmark this page and ensure you check it regularly.
Jeromin and colleagues discuss the use of magnetic resonance imaging (MRI) as a neuroimaging approach in the development of novel treatments for Alzheimer's disease (AD), including its role as a biomarker in clinical trials.
18F-fluorodeoxyglucose (18F-FDG) PET/CT can be successfully performed at extended injection-to-scan acquisition times while maintaining diagnostic image quality and has potential for real-time use of 18F-FDG PET/CT imaging in conjunction with interventional and surgical procedures.
Reducing the number of target lesions to up two per organ and five in total does not significantly reduce the results of immune-related response assessment in advanced melanoma patients treated with ipilimumab
Martinez-Ramirez and colleagues review the pathophysiology and clinical implications of cerebral microbleeds and the link with cognitive impairment and Alzheimer's disease (AD).
Canine lacrimal glands are visible on postcontrast thin slice computed tomographic (CT) images, allowing for presentation of normal reference measurements and volumes of this structure, which could aid in the evaluation of lacrimal gland disease.
News from around the web
Editor-in-Chief, Cardiovascular Ultrasound